The 5th U.S. Circuit Court of Appeals in New Orleans ruled Wednesday that the Food and Drug Administration’s initial approval of mifepristone in 2000 should remain in effect. » Read More
Researchers suggest the findings indicate that the devices could be a cheap way to reduce the potential impact of hearing loss on dementia. » Read More